DLI Teaching Faculty

Professor Steven Bull, Dean of the Leicester International Institute, Dalian University of Technology

史蒂文·布尔教授——大连理工大学莱斯特国际学院英方院长

Professor Steven Bull was appointed Dean of the Leicester International Institute (DLI) at Dalian University of Technology in 2026. He is Professor of Organic Chemistry at the University of Leicester and was Head of the School of Chemistry from 2023 to 2026, leading 70 academic and technical staff and approximately 750 students.

史蒂文·布尔教授于2026年出任大连理工大学莱斯特国际学院英方院长。他同时担任英国莱斯特大学有机化学教授，并于2023年至2026年间任化学学院院长，领导由70名学术及技术人员组成的团队，管理约750名学生。

Professor Bull obtained his BSc (Joint Honours) in Chemistry and Biochemistry (1986) and PhD (1986–1990) in biocatalysis from the University of Wales, Cardiff. He undertook postdoctoral research at the University of Queensland (1991–1993) and the University of Oxford (1994–1996), followed by a research position in Drug Discovery at Oxford Asymmetry. He was then a Lecturer at St Catherine's College, University of Oxford (1998–2001).

布尔教授于1986年在卡迪夫大学威尔士学院获得化学与生物化学联合荣誉学士学位，并于1990年获得生物催化方向博士学位。此后，他先后在昆士兰大学（1991–1993年）和牛津大学（1994–1996年）从事博士后研究，随后在Oxford Asymmetry公司担任药物发现研究职位。1998年至2001年，他在牛津大学圣凯瑟琳学院任讲师。

He joined the University of Bath in 2001, progressing to Professor of Organic Chemistry (Research) in 2015 and serving as Head of Organic Chemistry from 2011 to 2018. He joined the University of Leicester in 2023 as Professor of Organic Chemistry and Head of School, where he leads a research group developing new synthetic methods to address biological and sustainability challenges.

2001年，布尔教授加入巴斯大学，于2015年晋升为有机化学（研究）教授，并在2011年至2018年间担任有机化学学科负责人。2023年，他加入莱斯特大学，担任有机化学教授及化学学院院长，领导研究团队致力于开发新型合成方法，应对生物学及可持续发展领域的挑战。

Professor Bull is an internationally recognised organic chemist with more than 30 years of academic and industrial research experience. His research spans sustainable chemical technologies, drug discovery, chemical biology, catalysis and sensing. He has published more than 250 research papers and eight patents, with more than 15,000 citations and an H-index of 58 and has supervised more than 50 PhD students and 25 postdoctoral researchers from more than 10 countries.

布尔教授是国际公认的有机化学家，拥有超过30年的学术与工业研究经验。其研究涵盖可持续化学技术、药物发现、化学生物学、催化及传感等领域。他已发表研究论文逾250篇，拥有8项专利，论文被引次数超过15,000次，H指数达58。此外，他已指导来自10余个国家的50余名博士生及25名博士后研究人员。

Overt the last 20 years, he has secured more than £7 million in research grants and contracts from more than 15 sources, including EPSRC, BBSRC, the Royal Society, the Leverhulme Trust, industry and international funding agencies. His industrial collaborations include GSK, AstraZeneca, Evotec and Syngenta, reflecting a strong track record of translating research into industrial and pharmaceutical applications.

在过去20年间，布尔教授从EPSRC、BBSRC、英国皇家学会、Leverhulme Trust、工业界及国际资助机构等15余个渠道累计获得逾700万英镑的研究经费及合同。其工业合作伙伴包括葛兰素史克（GSK）、阿斯利康（AstraZeneca）、Evotec及先正达（Syngenta），充分体现了其研究成果向工业及制药应用转化的卓越能力。

Professor Bull has extensive international research experience, with collaborations across China, Japan, Korea, the USA, Europe and Australia. His Chinese collaborations have resulted in 35 joint publications, and he has supervised eight Chinese PhD students. He has also delivered research seminars at more than 25 Chinese universities and conferences.

布尔教授具有广泛的国际研究合作经验，与中国、日本、韩国、美国、欧洲及澳大利亚等国同行保持密切合作。其中，与中国学者的合作已产出联合发表论文35篇，并指导了8名中国博士生。他还曾在全国25余所高校及学术会议上作学术报告。

His research has received international recognition through numerous prizes and fellowships, including the 2026 CASE Prize for Catalysis, Sensing and the Environment, the Daiwa Prize for UK–Japan research collaboration, an Australian Research Council International Research Fellowship and a Royal Society Industrial Fellowship.

布尔教授的研究成果屡获国际殊荣，包括2026年CASE催化、传感与环境奖、日本国际协力机构颁发的Daiwa英日研究合作奖、澳大利亚研究理事会国际研究奖学金及英国皇家学会工业奖学金等。

Professor Bull has played an important role in developing the University of Leicester's partnership with Dalian University of Technology (DUT) since 2022, helping deliver the DLI undergraduate Pharmaceutical Chemistry programme that commenced in September 2025.

自2022年以来，布尔教授在推动莱斯特大学与大连理工大学合作方面发挥了重要作用，助力药学本科专业于2025年9月顺利招生开学。

As Dean of DLI, Professor Bull brings expertise in synthetic and pharmaceutical chemistry, drug discovery and chemical biology, together with longstanding research links with China, that will support the continued development and future success of DLI's transnational education programmes.

作为莱斯特国际学院英方院长，布尔教授将发挥在合成化学、药物化学、药物发现及化学生物学等领域的深厚专长，加之其与中国长期建立的研究联系，为莱斯特国际学院跨境教育项目的持续发展与未来成功提供有力支撑。